Edwards Lifesciences Corporation (EW) Q4 2007 Earnings Results

Edwards Lifesciences Beats on EPS, Stock Up 0.23%

Edwards Lifesciences reported a better-than-expected EPS, which contributed to a slight increase in stock price. The positive sentiment was driven by strong demand for their products, although no revenue figures were disclosed. Investors may be encouraged by management's confidence in future growth despite the lack of specific guidance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.56	N/A	+6.67%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a positive outlook regarding product demand. However, they did not provide specific guidance for future quarters.

Management highlighted strong demand for their heart valve products.

They expressed confidence in their long-term growth strategy.

Edwards Lifesciences Beats on EPS, Stock Up 0.23%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Beats on EPS, Stock Up 0.23%

Key numbers

Management commentary